Professor Lesley Anderson is Academic Lead for the Industrial Centre for Artificial Intelligence in Digital Diagnostics (iCAIRD) for Grampian. She is leading artificial intelligence evaluations at the University of Aberdeen.
Prof Anderson joined the Aberdeen Centre for Health Data Science at the University of Aberdeen in March 2020. She trained at Queen’s University Belfast (QUB) graduating with a PhD in cancer epidemiology in 2004 and an undergraduate degree (first class Honours) in Biomedical Science in 2001. She has a Masters in Population Health-based Evidence obtained by distance learning from the University of Manchester (distinction level) in 2006. Professor Anderson joined QUB as an academic in 2010 after completing two highly respected fellowships: an Academic Fellowship (funded by the UK Medical Research Council) and a Cancer Prevention Fellowship at the National Cancer Institute, National Institute of Health, Maryland, United States of America. Professor Anderson then joined the Northern Ireland Cancer Registry (NICR) in 2017 as Deputy Director overseeing the production of Official Statistics for Northern Ireland and developing the NICR Research Advisory Group.
* Cancer prevention,* Cancer diagnosis,* Cancer prognosis,* Health Data Science,* Artificial Intelligence Evaluations,* Multi-centre research studies,* Cancer Registration
Published peer-reviewed articles (n=112 – 10/03/2022).
Supporting someone with cancer during the COVID-19 pandemic: A mixed methods analysis of cancer carer’s health, Quality of Life and need for support. Santin O, McMullan J, Jenkins C, Anderson LA, McShane CM. Health & Social Care in the Community Dec 2021. (In press).
Interpretation and Reporting of Predictive or Diagnostic Machine Learning Research in Trauma & Orthopaedics. Farrow L, Zhong M, Anderson L, Aschcroft GP. Bone and Joint Journal. 2021 BJJ-2021-0851.R1 (In press)
A National Network of Safe Havens: A Scottish Perspective. Chuang Gao, Mark McGilchrist, Shahzad Mumtaz, Christopher Hall, Lesley Ann Anderson, John Zurowski, Sharon Gordon, Joanne Lumsden, Vicky Munro, Artur Wozniak, Michael Sibley, Christopher Banks, Chris Duncan, Pamela Linksted, Alastair Hume, Catherine L Stables, Charlie Mayor, Jacqueline Caldwell, Katie Wilde, Christian Cole, Emily Jefferson (in press).
Menopausal hormone therapy and risk of biliary tract cancers. Sarah S. Jackson, Ruth M. Pfeiffer, Chiara Gabbi, Lesley Anderson, Shahinaz M. Gadalla, and Jill Koshiol. Hepatology 2021 (Online ahead of print – PMID: 34766362).
Spatial disparities in the reported incidence and survival of myeloproliferative neoplasms in Australia. Cameron JK, Fritschi L, Ross DM, Anderson LA, Baade P. Pathology 2021 (Online ahead of print – PMID: 34128913).
The psychosocial impact of the COVID-19 pandemic on MGUS, smouldering and active myeloma patients: findings from an international survey. Quinn SI, Anderson LA, Lohfeld L, McShane C. British Journal of Haematology. 2021;194(2):294-297.
Germline variation in the insulin-like growth factor pathway and risk of Barrett’s esophagus and esophageal adenocarcinoma. Dighe SG, Chen J, Yan L, He Q, Gharahkhani P, Onstad L, Levine DM, Palles C, Ye W, Gammon MD, Iyer PG, Anderson LA, Liu G, Wu AH, Dai JY, Chow WH, Risch HA, Lagergren J, Shaheen NJ, Bernstein L, Corley DA, Prenen H, deCaestecker J, MacDonald D, Moayyedi P, Barr H, Love SB, Chegwidden L, Attwood S, Watson P, Harrison R, Ott K, Moebus S, Venerito M, Lang H, Mayershofer R, Knapp M, Veits L, Gerges C, Weismüller J, Gockel I, Vashist Y, Nöthen MM, Izbicki JR, Manner H, Neuhaus H, Rösch T, Böhmer AC, Hölscher AH, Anders M, Pech O, Schumacher B, Schmidt C, Schmidt T, Noder T, Lorenz D, Vieth M, May A, Hess T, Kreuser N, Becker J, Ell C, Ambrosone CB, Moysich KB, MacGregor S, Tomlinson I, Whiteman DC, Jankowski J, Schumacher J, Vaughan TL, Madeleine MM, Hardie LJ, Buas MF. Carcinogenesis. 2020;42(3):369-377.
Patient’s perspectives of living with a precancerous condition: monoclonal gammopathy of undetermined significance (MGUS). Murphy B, McShane CM, Santin O, Treanor C, Bryne B, Donnelly M, Anderson LA. European Journal of Oncology Nursing 2021;51:101901.
Changes in the Demographic and Clinicopathological Characteristics of Thyroid Cancer: A Population-Based Investigation in Algeria, 1993-2013. Boukheris H, Bettayeb A, Anderson LA, Zineb A, Benbachir FZ, Attar S, Saim H, Rouigeb K, Berber N. Journal of Cancer Epidemiology, Article ID 7812791, 11 pages, 2020.
Sex-specific Genetic Associations for Barrett’s Esophagus and Esophageal Adenocarcinoma. Dong J, Maj C, Tsavachidis S, Ostrom QT, Gharahkhani P, Anderson LA, Wu AH, Ye W, Bernstein L, Borisov O, Schröder J, W-H, Gammon MD, Liu G, Caldas C, Pharoah PD, Risch HA, May A, Gerges C, Anders M, Venerito M, Schmidt T, Izbicki JR, Hölscher AH, Schumacher B, Vashist Y, Neuhaus H, Rösch T, KnappM, Krawitz P, Böhmer A, Iyer PG, Reid BJ, MacGregor S, Lagergren J, Shaheen NJ, Corley DA, Gockel I, Fitzgerald RC, Stomach and Oesophageal Cancer Study (SOCS) consortium, Cook MB, Whiteman DC, Vaughan TL, Schumacher J & Thrift AP. Gastroneterology 2020;159(6):2065-2076.
Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus. Xie S, Fang R, Huang M, Dai J, Thrift A, Anderson L, Chow W, Bernstein L, Gammon MD, Risch HA, Shaheen NJ, Reid BJ, Wu AH, Iyer PG, Liu G, Corley DA, Whiteman, D. C., Caldas C, Pharoah PD, Hardie L J, Fitzgerald RC, Shen H, Vaughan TL, Lagergren J. Clinical Gastroenterology and Hepatology, 2020;18(12):2701-2709.
Improving Identification of Cognitive Impairment in Fragility Fracture Patients: Impact of Educational Guidelines on Current Practice. Kennedy GRM, Mohandas P, Anderson LA, Kennedy M, Shirley DSL. Geriatr Orthop Surg Rehabil 2020;11:1-7.
Does risk of progression from Barrett’s esophagus to esophageal adenocarcinoma change based on the number of non-dysplastic endoscopies? Kunzmann A, Coleman HG, Johnston BT, Turkington RC, McManus D, Anderson LA, Thrift AP. Digestive Diseases and Sciences. 2021, 66(6): 1965-1973.
Rare thyroid malignancies in Europe: data from the information network on rare cancers in Europe (RARECAREnet). Locati LD, Cavalieri S, Dal Maso L, Busco S, Anderson LA, Botta L, Bento MJ, Carulla M, Lopez MDC, Fusco M, Guevara M, Innos K, Johannesen TB, Micallef R, Minicozzi P, Panato C, Petrova D, Rubio-Casadevall J, Smailyte G, Vitale MF, Trama A. Oral Oncology, 2020 Sep;108:104766.
Cancer incidence projections in Northern Ireland to 2040. Donnelly D, Gavin AT, Anderson LA. CEBP 2020;29(7):1398-1405.
Modifiable lifestyle and medical risk factors associated with myeloproliferative neoplasms. Duncombe AS, Anderson LA, James G, de Vocht F, Fritschi L, Mesa R, Clarke M, McMullin MF. HemaSphere 2020; 4(1):e327.
Comparison of molecular assays for HPV testing in oropharyngeal squamous cell carcinomas: a population-based study in Northern Ireland. Craig SG, Anderson LA, Moran M, Graham L, Currie K, Rooney K, Robinson M, Bingham V, Cuschieri KS, McQuaid S, Schache AG, Jones TM, McCance D, Salto-Tellez M, McDade SS, James JA. CEBP 2020; 29(1):31-38.
Association Between Levels of Hormones and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus. Xie SH, Fang R, Huang M, Dai J, Thrift AP, Anderson LA, Chow WH, Bernstein L, Gammon MD, Risch HA, Shaheen NJ, Reid BJ, Wu AH, Iyer PG, Liu G, Corley DA, Whiteman DC, Caldas C, Pharoah PD, Hardie LJ, Fitzgerald RC, Shen H, Vaughan TL, Lagergren J.Clin Gastroenterol Hepatol. 2019; 18(12):2701-2709.
Association between Aspirin Use and Biliary Tract Cancer Survival. Jackson SS, Pfeiffer RM, Liu Z, Anderson LA, Tsai H-T, Gadalla S, Koshiol J. JAMA Oncology 201, 5(12):1802-1804. Erratum in:JAMA Oncol. 2019 Dec 1;5(12):1811.
Predictors of an early death in patients diagnosed with colon cancer: A retrospective case-control study in the UK. Donnelly C, Hart, N, McCrorie AD, Donnelly M, Anderson L, Ranaghan L, Gavin A. BMJ Open 2019;9(6):e026057.
Professor Lesley Anderson has over 20 years experience in research utilising healthcare data from the United Kingdom, Ireland, USA and Europe. She has established international partnerships within the USA, Europe, Australia, Africa and Asia to facilitate research in the fields of health data science and public health with a focus on cancer research. Global Health Research Partnerships with researchers in Angola, Mongolia and Vietnam are seeking to identify ways to improve public knowledge and reduce the burden of cancer.